Literature DB >> 33767943

Complications and Patient-reported Outcomes in Transfemale Vaginoplasty: An Updated Systematic Review and Meta-analysis.

Samyd S Bustos1, Valeria P Bustos2, Andres Mascaro3, Pedro Ciudad4, Antonio J Forte2,5, Gabriel Del Corral6, Oscar Javier Manrique7.   

Abstract

Vaginoplasty aims to create a functional feminine vagina, sensate clitoris, and labia minora and majora with acceptable cosmesis. The upward trend in the number of transfemale vaginoplasties has impacted the number of published articles on this topic. Herein, we conducted an updated systematic review on complications and patient-reported outcomes.
METHODS: A update on our previous systematic review was conducted. Several databases including MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus were assessed. Random effects meta-analysis and subgroup analyses were performed.
RESULTS: After compiling the results of the update with the previous systematic review, a total of 57 studies pooling 4680 cases were included in the systematic review, and 52 studies were used in the meta-analysis. Overall pooled data including any surgical technique showed rates of 1% [95% confidence interval (CI) <0.1%-2%] of fistula, 11% (95% CI 8%-14%) of stenosis and/or strictures, 4% (95% CI 1%-9%) of tissue necrosis, and 3% (95% CI 1%-4%) of prolapse. Overall satisfaction was 91% (81%-98%). Regret rate was 2% (95% CI <1%-3%). Average neovaginal depth was 9.4 cm (7.9-10.9 cm) for the penile skin inversion and 15.3 cm (13.8-16.7 cm) for the intestinal vaginoplasty.
CONCLUSIONS: Transfemale vaginoplasty is a key component of the comprehensive surgical treatment of transfemale patients with gender dysphoria. Over time, we will see an increased demand for these procedures, so adequate surgical training, clinical/surgical experience, and research outcomes are required, as we continue to strive to provide the best care possible for a population in need.
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.

Entities:  

Year:  2021        PMID: 33767943      PMCID: PMC7984836          DOI: 10.1097/GOX.0000000000003510

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


INTRODUCTION

Transgender is a term that includes the many ways that people’s gender identities can differ from the sex they were assigned at birth. Unfortunately, the transgender population has largely suffered from transgender-related discrimination in healthcare and employment, and from high rates of mental illness, particularly anxiety and depression, in addition to violence and health-related problems.[1,2] This population expresses their gender identity in many different ways. Some use their dress or behavior (gender expressions) to live as the gender that feels appropriate for them, and many undergo medical or surgical treatment to change their body, so that it matches their gender identity. Surgical treatment, particularly genital or bottom surgery, is often the last and most considered step for transgender patients.[3] The role of surgery has shown to be essential and medically necessary to alleviate patients’ gender dysphoria, which is the distress caused by the discrepancy between a person’s gender identity and the sex assigned at birth.[4-10] For transgender women, genital surgery involves vaginoplasty, which entails the surgical reconstruction of all the anatomical structures of the female external genitalia and the creation of a functional vaginal canal. The Standards of Care from the World Professional Association for Transgender Health clearly defines the criteria for vaginoplasty in transfemale patients, which includes the following: persistent, well-documented gender dysphoria, capacity to make a fully informed decision and to consent for treatment, age of majority, control of significant medical or mental health concerns, 12 continuous months of hormonal therapy as appropriate, and 12 continuous months of living in a gender role that is congruent with their gender identity.[3] In general, vaginoplasty aims to create a functional feminine vulva, a deep and wide enough vagina, a hooded sensate clitoris, and labia minora and majora with acceptable cosmesis and sexual sensation. A number of surgical techniques have been described; however, the most commonly used technique is still the penile skin inversion with or without skin graft. Although less common, intestinal-based techniques, including colon or small bowel conduits, have also been reported. These may have specific indications; for instance, patients with micropenis, penile hypoplasia (<8 cm), or poor skin quality or elasticity due to prolonged hormonal treatment may not be suitable for penile skin inversion and other options such as intestinal conduits may be more appropriate.[11,12] Although there are still financial and social barriers to healthcare access for this particular population worldwide, the need for surgical gender-affirming care is increasing remarkably. This may be explained due to increased awareness of the needs of transgender and gender-nonbinary (TGNB) patients, and availability and accessibility to gender care centers. In 2015, the US Transgender Surgery sampled over 27,000 TGNB Americans and found that one fourth had undergone one or more gender affirmation surgeries (GAS).[13,14] A total of 12% of respondents had undergone vaginoplasty and/or labiaplasty, and 54% responded they wanted to have it someday. Therefore, both academic and private centers are facing an increased demand for transfemale vaginoplasty. The need of a state-of-the-art review on surgical and patient-reported outcomes has been previously addressed by Manrique et al.[5] However, this upward trend in gender affirmation surgeries has also impacted the number of published articles on this topic over the past years about this surgical procedure. In this study, we aim to conduct an updated, comprehensive systematic review of the literature of papers in transfemale vaginoplasty with meta-analysis of complications and patient-reported outcomes.

METHODS

Search Methodology

Based on the PRISMA guidelines, a comprehensive research of several databases from each database’s inception was conducted on July 15, 2020.[15] The databases included PubMed, Ovid MEDLINE Epub Ahead of Print, Ovid Medline In-Process and Other Non-Indexed Citations, Ovid MEDLINE, Ovid EMBASE, Web of Science, and Ovid Cochrane Central Register of Controlled Trials. A comprehensive research strategy using the same strategy from our previous study was conducted.[5] This was previously designed and conducted by experienced librarians with input from the study’s principal investigator. Controlled vocabulary with keywords was conducted to update the previous search and include studies from 2017 to 2020 of vaginoplasty in transgender and nonbinary population who reported our outcomes of interest. The search terms were formulated using the PICO structure. Participants included transfemale patients. The intervention was vaginoplasty, bottom male-to-female surgery, or transfemale genital surgery. Comparisons addressed the specific technique used. Outcomes included complications, functional or aesthetic patient-reported outcomes. The strategy is available in Supplemental Digital Content 1. (See pdf, Supplemental Digital Content 1, which displays the search strategies, http://links.lww.com/PRSGO/B611.) All search results were combined in EndNote, a bibliographic management tool, and duplicates were removed.

Study Selection

We conducted a 2-stage screening process with the help of the online software Covidence.[16] Search strategy results were exported from EndNote into XML format and uploaded to Covidence.[16] Two researchers (S.S.B and V.P.B) conducted the first screening by reviewing titles and abstracts, and selected the ones relevant to the research question. Then, the second screening was conducted by the same researchers reviewing the full-text form of the remained articles. The studies included were those that met the inclusion and exclusion criteria. Conflicts in this stage were solved by a third reviewer (O.J.M.), who moderated a discussion and made final decision. Eligible criteria were based on our previous systematic review and meta-analysis by Manrique et al.[5] Inclusion criteria were all articles that included studies with sample size more than 5 patients, only transfemale vaginoplasty procedures studied, publication year 1985 or more, articles reporting at least 1 outcome measurement, and a follow-up time of at least 1 year. The exclusion criteria were all studies with surgical techniques for partial reconstruction of the vagina or vaginoplasty corrections, surgical techniques only for the creation of neoclitoris or labiaplasty, and unspecified surgical technique, non-English publications, cancer-related publications, trauma-related publications, and congenital-related publications.

Data Extraction and Synthesis

The included studies were analyzed in detail. We extracted information regarding the name of the first author, year of publication, and follow-ups time (minimum, maximum, and SDs variables). Major complications categorized as fistulas, vaginal and urethral stenosis and strictures, tissue necrosis, and prolapse were identified. For fistulas outcomes, vaginorectal and vesicovaginal fistulas were included. Stenosis and strictures outcomes included introital, stroma, urethral, and vaginal. Both partial and complete strictures were taken into account. The tissue necrosis outcome included necrosis of the urethra, glans, clitoris, and labia. Rectocele, urethral, or mucosal prolapse was included in the prolapse outcome. Patient-reported outcomes were analyzed as proportions and percentages. Overall results, function, and aesthetic satisfaction outcomes were identified as the number of patients who reported such variables. Aesthetic outcome included perception of vaginal appearance as feminine. Satisfied included “very satisfied” and “mostly satisfied” in the included studies. The ability to have orgasm, regret rate, and the patient-reported outcomes were analyzed as proportions and percentages. In addition, we extracted information about the vaginal cavity length, its mean, minimum and maximum values, and SD.

Quality Assessment

The Newcastle-Ottawa Scale was used to assess quality of nonrandomized studies in meta-analyses was used to assess the risk of bias in the included studies. A nonrandomized study can be ranked 9 stars on items related to: the selection of the study groups (4 points), comparability of the exposed and unexposed groups (2 points), and the ascertainment of outcomes of interest (3 points).

Statistical Analysis

The data were analyzed, and outcome estimations in this meta-analysis were conducted in Stata Software/IC (version 16.1).[17] We divided the studies in 2 major groups of interest: penile inversion technique and intestinal vaginoplasty. Given the heterogeneity between studies, we conducted a logistic-normal-random-effect model. The study-specific proportions with 95% exact confidence intervals (CIs) and overall pooled estimates with 95% Wald CIs with Freeman–Turkey double arcsine transformation were performed. The effect size and percentage of weight were presented for each individual study. To evaluate heterogeneity, I2 statistics was used. If P value <0.05 or I 2>50% significant heterogeneity was considered.

RESULTS

A total of 154 articles were identified in the updated search. The first screening process generated 36 articles, and the second screening yielded 11 articles, which were included in the systematic review and meta-analysis. We compiled these data to the one of the previous systematic review and meta-analysis of Manrique et al[5] as shown in Figure 1. A total of 57 studies were included in the systematic review and 52 in the meta-analysis. All included studies were assigned either a low- or moderate-quality design. (See pdf, Supplemental Digital Content 2, which displays the quality assessment of included studies, http://links.lww.com/PRSGO/B612.)
Fig. 1.

PRISMA flowchart.

PRISMA flowchart.

Study Characteristics

A total of 4680 cases were represented in this systematic review. A total of 39 (75%) studies used the penile skin inversion technique with or without scrotal flap[18-54] and 11 (21.2%) studies used bowel pedicle flaps, of which 7 (13.5%) used sigmoid or rectosigmoid, 3 (5.8%) used ileal, and 1 (1.9%) used transverse colon as conduit.[55-67] One study (1.9%) reported both techniques,[68] and another study (1.9%) reported outcomes using amnion grafts with and without fibroblasts.[69] A total of 3930 (84.0%) cases used the penile skin inversion technique with or without scrotal graft or skin graft, whereas 726 (15.5%) cases used bowel pedicle flaps. One study reported 24 (0.5%) vaginoplasty cases using amnion grafts. The average number of cases per study was 90 with the smallest study including 7 cases and the largest study including 475. Table 2 shows the differences between the findings of our previous meta-analysis and the current study.
Table 2.

Differences between the Previous and Current Metanalysis

Manrique et al 2018Current StudyDifferences
Complications
FistulaOverall2% (1%–6%)1% (<0.1%–2%)−1%
PSI1% (%–4%)1% (<0.1%–2%)=
IBV6% (%–20%)2% (<0.1%–9%)−4%
Stenosis and stricturesOverall14 (10%–18%)11% (8%–14%)−3%
PSI13% (9%–18%)10% (8%–14%)−3%
IBV17% (10%–29%)14% (5%–26%)−3%
Tissue necrosisOverall1% (0%–6%)4% (1%–9%)+3%
PSI1% (0%–6%)5% (1%–10%)+4%
IBVNR1% (<0.1%–9%)
ProlapseOverall4% (2%–10%)3% (1%–4%)−1%
PSI3% (1%–8%)2% (1%–4%)−1%
IBV8% (2%–43%)6% (1%–14%)−2%
Patient-reported outcomes
Overall resultsOverall93% (79%–100%)91% (81%–98%)−2%
PSI91% (75%–100%)87% (78%–94%)−4%
IBV100% (96%–100%)99% (97%–100%)−1%
Function outcomeOverall87% (75%–96%)87% (77%–94%)=
PSI88% (71%–99%)87% (74%–96%)−1%
IBV86% (75%–95%)86% (75%–95%)=
Aesthetic outcomeOverall90% (79%–98%)90% (84%–94%)=
PSI91% (78%–99%)90% (84%–95%)−1%
IBV86% (69%–94%)86% (69%–94%)=
Ability to have an orgasmOverall70% (54%–84%)76% (64%–86%)+6%
PSI68% (52%–83%)73% (60%–84%)+5%
IBV89% (72%–96%)95% (88%–99%)+6%
RegretsOverall1% (<1%–3%)2% (<1%–3%)+1%
PSI2% (<1%–4%)2% (<1%–4%)=
IBV0%0% (<1%–20%)=
Vaginal cavity length
Overall12.2 cm (10.2–14.2 cm)10.9 cm (9.2–12.8)−1.3 cm
PSI10.7 cm (8.8–12.5 cm)9.4 cm (7.9–10.9)−1.3 cm
IBV15.3 cm (14.3–16.4 cm)15.3 cm (13.8–16.7cm)=

Data shown as pooled value and 95% confidence interval.

IBV, intestinal-based vaginoplasty; PSI, penile skin inversion; =, no change.

Study Characteristics N, no; NS, not specified; Y, yes. Differences between the Previous and Current Metanalysis Data shown as pooled value and 95% confidence interval. IBV, intestinal-based vaginoplasty; PSI, penile skin inversion; =, no change.

Complications

Overall pooled data including both surgical techniques showed the following complication rates: 1% (95% CI <0.1%–2%, I2 = 65.8%) of fistula, 11% (95% CI 8%–14%, I2 = 87.3%) of stenosis and/or strictures, 4% (95% CI 1%–9%, I2 = 94.3%) of tissue necrosis, and 3% (95% CI 1%–4%, I2 = 77.2%) of prolapse (Fig. 2).
Fig. 2.

Meta-analyses of different types of complications. Fistula (A), tissue necrosis (B), stenosis and strictures (C), and prolapse (D) are depicted.

Meta-analyses of different types of complications. Fistula (A), tissue necrosis (B), stenosis and strictures (C), and prolapse (D) are depicted. Subgroup meta-analysis showed the following outcome complications for the penile skin inversion technique with or with our scrotal flaps: 1% (<0.1%–2%, I2 = 57.5%) of fistula, 10% (8%–14%, I2 = 85.5%) of stenosis and strictures, 5% (1%–10%, I2 = 93.9.0%) of tissue necrosis, and 2% (1%–4%, I2 = 78.1%) of prolapse. Complications for intestinal vaginoplasty were as follows: 2% (<0.1%–9%, I2 = 83.3%) of fistula, 14% (5%–26%, I2 = 91.7%) of stenosis and strictures, 1% (<0.1%–2%) of tissue necrosis in 1 study, and 6% (1%–14%, I2 = 76.4%) for prolapse. Complications reported for the 2 surgical techniques had an I2 value greater than 50% representing considerable heterogeneity.

Patient-reported Outcomes

Satisfaction rates were 91% (81%–98%, I2 = 94.8%), 87% (77%–94%, I2 = 88.6%), and 90% (84%–94%, I2 = 69.4%) for overall, functional, and aesthetic outcomes, respectively (Fig. 3). For the penile skin inversion technique, patient-reported outcomes showed a satisfaction rate of 87% (78%–94%, I2 = 88.3%) for overall satisfaction, 87% (74%–96%, I2 = 90.9%) for functional outcomes, and 90% (84%–95%, I2 = 71.0%) for aesthetical outcomes. For the intestinal vaginoplasty technique, patient-reported outcomes showed a satisfaction rate of 99% (97%–100%) for overall satisfaction, 86% (75%–95%, I2 = 55.3%) for functional outcomes, and 86% (69%–94%) for aesthetic outcomes.
Fig. 3.

Meta-analyses of different types of patient-reported outcomes. Overall satisfaction (A), functional outcomes (B), and aesthetic outcomes (C) are depicted.

Meta-analyses of different types of patient-reported outcomes. Overall satisfaction (A), functional outcomes (B), and aesthetic outcomes (C) are depicted. Overall, the ability to achieve orgasm was 76% (64%–86%, I2 = 93.1%). In the subgroup analysis, the ability to achieve orgasm was 73% (60%–84%, I2 = 92.8) for the penile skin inversion technique and 95% (88%–99%) for intestinal vaginoplasty (Fig. 4).
Fig. 4.

Meta-analysis of ability to achieve orgasm.

Meta-analysis of ability to achieve orgasm. The overall regret rate was 2% (95% CI <1%–3%, I2 = 0%). The regret rate was 2% (95% CI <1%–4%, I2 = 0%) for the penile inversion technique and <1% (95% CI <1%–20%) for the intestinal-based vaginoplasty group (Fig. 5).
Fig. 5.

Meta-analysis of regret rates.

Meta-analysis of regret rates.

Vaginal Cavity Dimensions

Fifteen studies reported vaginal cavity length (Fig. 6). The average neovaginal length for both surgical techniques was 10.9 cm (9.2–12.8 cm, I2 = 93.5%). In the subgroup analysis, the average length was 9.4 cm (7.9–10.9 cm, I2 = 84.6%) for the penile skin inversion technique and 15.3 cm (13.8–16.7 cm, I2 = 0.0%) for the intestinal vaginoplasty group.
Fig. 6.

Meta-analysis of depth of neovagina. Weights are from random effects analysis.

Meta-analysis of depth of neovagina. Weights are from random effects analysis.

DISCUSSION

The gender confirmation process involves a comprehensive treatment program including endocrine therapy, psychological treatment, breast surgery, facial surgery, and genital confirmation surgery.[5] Of all treatment modalities, genital surgery is generally the final stage of the gender confirmation process and is associated with significant improvement in both mental and sexual quality of life.[5] Various techniques have been described for transfemale vaginoplasty; most of these techniques have been adapted from procedures designed to treat vaginal agenesis[70] An optimal or ideal technique has not yet been determined due to the lack of sufficiently large comparative studies. However, penile inversion using a pedicle penoscrotal skin flap seems to be the first-line approach, as it is technically less complex and invasive when compared to other techniques while providing great cosmetic and functional results. Nevertheless, patients with penile hypoplasia (penile shaft less than 8 cm) pose a challenge to the surgeon, as they usually do not have sufficient penile skin to create the neovaginal cavity. In such cases, skin grafts from the lower abdomen or thighs are necessary. Additionally, intestinal transposition vaginoplasty emerges as a reasonable option, in which rectosigmoid or ileal segments are isolated (through open or minimally invasive approach) and transferred into the neovaginal space. The advantage of using an intestinal conduit is its length, texture, lubrication, and appearance similar to a natural vagina. However, it should be noted that an abdominal surgery is required, and there is a risk of colitis, peritonitis, intestinal obstruction, junctional neuroma, introital stenosis, mucocele, and constipation.[71] Furthermore, colonic mucosa is more vulnerable to sexually transmitted diseases and further screening for colon cancer is required.[71,72] Various grafts such as pedicle genital or nongenital skin flaps have also been described.[11,12,70,72-74] Skin graft vaginoplasty is not limited by a vascular pedicle. This ensures that there can be significantly more skin harvested if required to line the neovaginal cavity. Nonetheless, a circumferential skin graft tends to scar and contract leading to neovaginal stenosis in 33%–45% of cases, representing a real disadvantage of this technique.[72,73] In addition, undesirable scarring and hypopigmentation of donor sites are also major drawbacks. Hence, this approach is less likely to be utilized in current surgical practice. However, skin grafting may be used as an adjunct of other approaches, for instance when there is not enough tissue for the creation of the neovagina from penile skin alone.[70] Other options for reconstructing a neovagina are emerging, and include, but are not limited to the use of buccal mucosa, amnion grafts, or decellularized tissue.[11] In our analysis, the vast majority of studies included penile skin inversion with or without scrotal flaps. However, with the updated search, we included 2 studies reporting intestinal-based vaginoplasties, one of which was the largest retrospective study among this group including a total of 386 sigma-lead rectosigmoid colon vaginoplasties in India.[67] Only 1 study with amnion grafts was identified but not included in the meta-analysis. In general, quality of the studies was either low or moderate. Most of them were retrospective studies with no control group. The largest study within the intestinal-based vaginoplasty group was conducted by Kaushik et al[67] in India and included a total of 386 sigma-lead rectosigmoid vaginoplasty. They reported a 20.2% complication rate of which the majority were minor complications (97.4%). A total of 11.4% required reoperations: 2.6% due to introital stricture and mucosal prolapse and 8.8% for elective minor aesthetic enhancement. Satisfaction was reported as 4.7 over a 5-point scale. Slight changes were identified in this updated meta-analysis as compared with the previous meta-analysis. The differences between studies in complication rates and in patient-reported outcomes including overall, functional, and aesthetic outcomes, ranged from 1 to 4 percentage points. This reflects a stable prevalence among these outcomes, which may be translated as neither an improvement nor a decline in surgical quality standards. From all the complications of interest, fistula had the lowest rate with only 1% (<0.1%–2%), whereas stenosis and strictures had the highest rate with 11% (8%–14%). For stenosis and strictures, intestinal-based vaginoplasty had the highest complication rate with 14% (5%–26%) compared with the penile skin inversion technique with 10% (8%–14%). However, stenosis rates were lower compared with the previous meta-analysis. Interestingly, the ability to achieve orgasm after both vaginoplasty techniques increased compared with the previous meta-analysis: from 70% (54%–84%) to 76% (64%–86%), respectively. The intestinal-based vaginoplasty technique reported the highest ability to achieve orgasm with 95% (88%–99%) compared with the penile skin inversion technique with 73% (60%–84%). This may be translated as an improvement in surgical techniques in preserving genital sensation. Very low regret rates have been a common denominator among transfemale patients who undergo vaginoplasty. The prevalence of regret was almost the same as our previous meta-analysis, with only 1 point of difference: 1% (<1%–3%) and 2% (<1%–3%), respectively. For vaginal length, there was a 1.3 cm of difference compared with our previous report. Hence, no important changes were presented with regard to these 2 outcomes. Gender confirmation surgery, and genital surgery particularly, does not fall within a single specialty’s scope of practice.[74] A multidisciplinary approach is typically required, involving endocrinology and psychology. It is essential to integrate mental health professionals, who are knowledgeable about the assessment and treatment of gender dysphoria and physical and sexual health in the preoperative and postoperative setting. The overall focus is to help maximize the patient´s psychological and physical state to improve quality of life.[3,75]

CONCLUSIONS

Transfemale vaginoplasty is a key component of the comprehensive surgical treatment of TGNB patients with gender dysphoria. To improve quality of care, a multidisciplinary approach is always necessary. Over the next several years, we will see an increase demand for these procedures, so adequate surgical training, clinical/surgical experience and research outcomes are very much needed, as we continue to strive to provide the best care possible for a population in need.

ACKNOWLEDGMENT

The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Table 1.

Study Characteristics

AuthorsYear of PublicationNo. CasesMean Follow-up (mo)Reported Complication Outcomes
Amend20132441.0Y
Goddard20072331.9Y
Hess201411962.6N
Krege200166NSY
Perovic20008956.0Y
Reed2011250NSY
Rossi201233224.3Y
Kim20032860.8Y
Djordjevic20112747.7Y
Wu20091114.2Y
Zhao20111935.1Y
Bouman2016423.2Y
Lenaghan199759NSY
Morrison2015832.2Y
van der Sluis201624289.6Y
Rehman1999570.1N
Jarolim2009134NSY
Hage1996609.6Y
van Noort19931616.6Y
Huang1994121NSY
Bouman198867NSY
Fang19919NSY
Eldh199320NSY
Buncamper20154949.9Y
LeBreton20162814.6Y
Raigosa20156024.3Y
Buncamper201647594.9Y
Wangiraniran2015395NSY
Sigurjonsson20168044.6Y
Papdopulos20174719.3N
Manrique201815146.0N
Imbimbo2009139NSN
Namba20077NSY
Siemssen19971130.6Y
Wagner20095036.5Y
Blanchard19872253.5N
Rubin1993133.5Y
Small1987110.7Y
Zavlin201740135.6N
Stein19901422.1N
Lindemalm19861314.1N
Manrique20194012.4Y
DiSumma201938NSY
Mukai201918NSN
Ferrando20207612.0Y
Levy20192402.9Y
Kaushik201938634.0Y
Nijhuis20204213.0Y
Thalaivirithan20183018.0Y
Seyed-Forootan20182436.0Y
Gaither20183303.0Y
Manero20189712.6Y

N, no; NS, not specified; Y, yes.

  70 in total

1.  Male-to-female vaginoplasty: Preecha's surgical technique.

Authors:  Burin Wangjiraniran; Gennaro Selvaggi; Prayuth Chokrungvaranont; Sirachai Jindarak; Sutin Khobunsongserm; Preecha Tiewtranon
Journal:  J Plast Surg Hand Surg       Date:  2014-10-30

2.  Gender-Confirmation Surgery Using the Pedicle Transverse Colon Flap for Vaginal Reconstruction: A Clinical Outcome and Sexual Function Evaluation Study.

Authors:  Oscar J Manrique; M Diya Sabbagh; Pedro Ciudad; Jorys Martinez-Jorge; Kidakorn Kiranantawat; Ngamcherd Sitpahul; Todd B Nippoldt; Ali Charafeddine; Hung-Chi Chen
Journal:  Plast Reconstr Surg       Date:  2018-03       Impact factor: 4.730

3.  Male-to-Female Gender Reassignment Surgery: An Institutional Analysis of Outcomes, Short-term Complications, and Risk Factors for 240 Patients Undergoing Penile-Inversion Vaginoplasty.

Authors:  Jason A Levy; Daniel C Edwards; Paulette Cutruzzula-Dreher; Brian H McGreen; Shawon Akanda; Susan Tarry; Laurence H Belkoff; Kathy L Rumer
Journal:  Urology       Date:  2019-06-14       Impact factor: 2.649

4.  Construction of a neovagina with preservation of the glans penis as a clitoris in male transsexuals.

Authors:  J Eldh
Journal:  Plast Reconstr Surg       Date:  1993-04       Impact factor: 4.730

5.  Laparoscopic vaginal reconstruction using an ileal segment.

Authors:  Ji-Xiang Wu; Bin Li; Wen-Zhi Li; Yong-Guang Jiang; Jie-Xiong Liang; Chen-Xi Zhong
Journal:  Int J Gynaecol Obstet       Date:  2009-08-07       Impact factor: 3.561

Review 6.  Masculinizing Genital Gender Confirmation Surgery.

Authors:  Miriam Hadj-Moussa; Shailesh Agarwal; Dana A Ohl; William M Kuzon
Journal:  Sex Med Rev       Date:  2018-08-16

7.  Aesthetic and functional male to female genital and perineal surgery: feminizing vaginoplasty.

Authors:  Harold Morgan Reed
Journal:  Semin Plast Surg       Date:  2011-05       Impact factor: 2.314

8.  Satisfaction with male-to-female gender reassignment surgery.

Authors:  Jochen Hess; Roberto Rossi Neto; Leo Panic; Herbert Rübben; Wolfgang Senf
Journal:  Dtsch Arztebl Int       Date:  2014-11-21       Impact factor: 5.594

9.  Primary Total Laparoscopic Sigmoid Vaginoplasty in Transgender Women with Penoscrotal Hypoplasia: A Prospective Cohort Study of Surgical Outcomes and Follow-Up of 42 Patients.

Authors:  Mark-Bram Bouman; Wouter B van der Sluis; Marlon E Buncamper; Müjde Özer; Margriet G Mullender; Wilhelmus J H J Meijerink
Journal:  Plast Reconstr Surg       Date:  2016-10       Impact factor: 4.730

Review 10.  Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery.

Authors:  Miriam Hadj-Moussa; Dana A Ohl; William M Kuzon
Journal:  Sex Med Rev       Date:  2018-06-08
View more
  1 in total

1.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.